日内瓦湖地区长期无创通气:适应证、患病率与模式
该横断面观察研究纳入日内瓦和沃州所有接受无创通气的489例患者,旨在描述15年间无创通气患病率、适应证及设备模式的变化。结果显示患病率较2000年增加2.5倍,达38/10万居民;中位年龄71岁,31%超过75岁,平均3±1.8种共病,55%肥胖。COPD(包括重叠综合征)是最主要患者组,其次为肥胖低通气综合征(26%)。日间Paco2多已正常化,治疗依从性满意,仅8%每日使用<3.5小时;双水平正压通气 spontaneous/timed 模式为默认模式(86%),自动滴定模式使用少。50%患者择期起始无创通气,82%在医院内起始,15%在门诊起始。
要点
- 长期无创通气患病率15年内增加2.5倍,达38/10万居民,患者中位年龄71岁、31%超过75岁。
- COPD(包括重叠综合征)是首位适应证,其次为肥胖低通气综合征(26%);55%患者肥胖,平均共病3±1.8种。
- 双水平正压通气 spontaneous/timed 模式为默认模式(86%),自动滴定模式使用少。
- 治疗依从性满意,仅8%患者每日使用无创通气<3.5小时。
- 无创通气起始方式:50%择期,82%在医院内,15%在门诊。
适用人群与场景
- 纳入日内瓦和沃州所有接受无创通气的患者,共489例,覆盖1288378名居民。
- 患者中位年龄71岁,31%超过75岁,平均3±1.8种共病,55%肥胖。
- COPD(包括重叠综合征)是最主要患者组,其次为肥胖低通气综合征(26%)。
处置流程与药物剂量
- 双水平正压通气 spontaneous/timed 模式为默认模式(86%),自动滴定模式使用少。
- 无创通气起始:50%择期,82%在医院内,15%在门诊。
研究设计与关键结果
- 横断面观察研究纳入489例无创通气患者,患病率较2000年增加2.5倍,达38/10万居民。
- 患者中位年龄71岁,31%超过75岁,平均3±1.8种共病,55%肥胖。
- COPD(包括重叠综合征)是最主要患者组,其次为肥胖低通气综合征(26%)。
- 日间Paco2多已正常化;依从性满意,仅8%每日使用<3.5小时。
- 双水平正压通气 spontaneous/timed 模式为默认模式(86%),自动滴定模式使用少。
- 无创通气起始:50%择期,82%在医院内,15%在门诊。
证据类型、等级与局限
- 证据类型:横断面观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该地区长期无创通气使用快速增加,患者老龄化、共病多且常肥胖,COPD是当前首位适应证,其次为肥胖低通气综合征。
- 双水平正压通气 spontaneous/timed 模式是默认模式(86%),自动滴定模式使用少。
- 治疗依从性满意,仅8%每日使用<3.5小时。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Noninvasive ventilation (NIV) is standard of care for chronic hypercapnic respiratory failure, but indications, devices, and ventilatory modes are in constant evolution.
RESEARCH QUESTION: To describe changes in prevalence and indications for NIV over a 15-year period; to provide a comprehensive report of characteristics of the population treated (age, comorbidities, and anthropometric data), mode of implementation and follow-up, devices, modes and settings used, physiological data, compliance, and data from ventilator software.
STUDY DESIGN AND METHODS: Cross-sectional observational study designed to include all subjects under NIV followed by all structures involved in NIV in the Cantons of Geneva and Vaud (1,288,378 inhabitants).
RESULTS: A total of 489 patients under NIV were included. Prevalence increased 2.5-fold since 2000 reaching 38 per 100,000 inhabitants. Median age was 71 years, with 31% being > 75 years of age. Patients had been under NIV for a median of 39 months and had an average of 3 ± 1.8 comorbidities; 55% were obese. COPD (including overlap syndrome) was the most important patient group, followed by obesity hypoventilation syndrome (OHS) (26%). Daytime Paco2 was most often normalized. Adherence to treatment was satisfactory, with 8% only using their device < 3.5 h/d. Bilevel positive pressure ventilators in spontaneous/timed mode was the default mode (86%), with a low use of autotitrating modes. NIV was initiated electively in 50% of the population, in a hospital setting in 82%, and as outpatients in 15%.
INTERPRETATION: Use of NIV is increasing rapidly in this area, and the population treated is aging, comorbid, and frequently obese. COPD is presently the leading indication followed by OHS.
TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT04054570; URL: www.clinicaltrials.gov.
参考来源
- Cantero C, Adler D, Pasquina P, et al. Long-Term Noninvasive Ventilation in the Geneva Lake Area: Indications, Prevalence, and Modalities. Chest. 2020. PMID: 32243941. doi:10.1016/j.chest.2020.02.064
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。